Precursor T-lymphoblastic lymphoma

Precursor T-lymphoblastic lymphoma
ICD-10
ICD-9
DiseasesDB
MedlinePlus
eMedicine
MeSH ID

Precursor T-lymphoblastic lymphoma is a type of non-Hodgkin lymphoma that arises from immature T-cells. It is considered a high-grade lymphoma and is closely related to acute lymphoblastic leukemia (ALL). This condition primarily affects adolescents and young adults, with a higher prevalence in males.

Pathophysiology

Precursor T-lymphoblastic lymphoma is characterized by the proliferation of immature T-lymphocytes in the thymus or other lymphoid tissues. These cells can infiltrate the bone marrow, lymph nodes, and other organs, leading to the clinical manifestations of the disease.

Clinical Presentation

Patients with precursor T-lymphoblastic lymphoma often present with symptoms such as lymphadenopathy, fever, night sweats, and weight loss. A mediastinal mass is a common finding, which can cause respiratory symptoms due to compression of the trachea or other structures in the thoracic cavity.

Diagnosis

The diagnosis of precursor T-lymphoblastic lymphoma is typically made through a combination of biopsy and immunophenotyping. A biopsy of the affected tissue will show a proliferation of immature T-cells, and immunophenotyping can confirm the T-cell origin of the lymphoma.

Treatment

Treatment for precursor T-lymphoblastic lymphoma usually involves intensive chemotherapy regimens similar to those used for acute lymphoblastic leukemia. Radiation therapy may also be used, particularly if there is a large mediastinal mass.

Prognosis

The prognosis for patients with precursor T-lymphoblastic lymphoma varies depending on several factors, including the stage of the disease at diagnosis and the patient's response to treatment. Early diagnosis and aggressive treatment can improve outcomes.

See also

• T-cell lymphoma
• Acute lymphoblastic leukemia
• Non-Hodgkin lymphoma

External links

• National Cancer Institute - Adult Non-Hodgkin Lymphoma Treatment